drugset / Trial / NCT03457662

Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With PAD and Claudication

NCT03457662

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this trial is to evaluate the safety and efficacy of sonodynamic therapy (SDT) on reducing atherosclerotic plaques inflammation among patients with symptomatic femoropopliteal peripheral artery disease.

Timeline

Start
2018-03-15
Primary completion
2018-12-18
Completion
2019-04-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Sinoporphyrin sodium Other / unclassified 0.2 mg/kg Intravenous